On Wednesday, September 25, the Senate Caucus on International Narcotics Control held a hearing on unregulated analogues of synthetic drugs and recent legislation proposed to address growing concern. Chairman Dianne Feinstein (D-Calif.) led the hearing that included testimony from Michael Botticelli, deputy director of the Office of National Drug Control Policy, and Joseph Rannazzisi, deputy assistant administrator at the Office
Written by Cameron Price, chapter leader of the Victoria University of Wellington SSDP chapter in New Zealand. New Zealand is a nation of just four and a half million people and 121 members of parliament (MPs). As a result of our small size and relatively high number of politicians, access to decision-makers is better than usual. This is particularly true